FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Edna Mozes

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Shaye Kivity; Moran Landau-Rabi; Edna Mozes; Nancy Agmon-Levin; Juan-Manuel Anaya; Maria Teresa Arango; Miri Blank; Joab Chapman; Aviva Katzav; Yaron Zafrir; Yehuda Shoenfeld
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.
Zev Sthoeger; Heidy Zinger; Ilan Asher; Amir Sharabi; Edna Mozes
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosus.
Smadar Lapter; Hava Ben David; Amir Sharabi; Heidy Zinger; Alona Telerman; Maya Gordin; Lin Leng; Richard Bucala; Idit Shachar; Edna Mozes
A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Edna Mozes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shaye Kivity; Moran Landau-Rabi; Edna Mozes; Nancy Agmon-Levin; Juan-Manuel Anaya; Maria Teresa Arango; Miri Blank; Joab Chapman; Aviva Katzav; Yaron Zafrir; Yehuda Shoenfeld
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupus.
BMC medicine 2013;11():90.
2013: Zev Sthoeger; Heidy Zinger; Ilan Asher; Amir Sharabi; Edna Mozes
The tolerogenic peptide, hCDR1, down-regulates the expression of interferon-α in murine and human systemic lupus erythematosus.
PloS one 2013;8(3):e60394.
2011: Smadar Lapter; Hava Ben David; Amir Sharabi; Heidy Zinger; Alona Telerman; Maya Gordin; Lin Leng; Richard Bucala; Idit Shachar; Edna Mozes
A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide.
Immunology 2011;132(1):87-95.
2010: Amir Sharabi; Smadar Lapter; Edna Mozes
Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Journal of autoimmunity 2010;34(2):87-95.
2010: Amir Sharabi; Edna Mozes
Bcl-xL affects the development of functional CD4 Tregs.
Arthritis research & therapy 2010;12(4):405.
2010: Amir Sharabi; Molly Dayan; Heidy Zinger; Edna Mozes
A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide.
Journal of clinical immunology 2010;30(1):34-44.
2009: Smadar Lapter; Anat Marom; Asher Meshorer; Anat Elmann; Amir Sharabi; Ezra Vadai; Adi Neufeld; Yejezkel Sztainberg; Shoshana Gil; Dmitriy Getselter; Alon Chen; Edna Mozes
Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide.
Arthritis and rheumatism 2009;60(12):3744-54.
2009: Eirik Bratland; Beate Skinningsrud; DAG UNDLIEN; Edna Mozes; Eystein S Husebye
T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.
The Journal of clinical endocrinology and metabolism 2009;94(12):5117-24.
2009: Hava Ben David; Amir Sharabi; Reshmi Parameswaran; Heidy Zinger; Edna Mozes
A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.
Immunology 2009;128(2):245-52.
2009: Amir Sharabi; Zev M Sthoeger; Keren Mahlab; Smadar Lapter; Heidy Zinger; Edna Mozes
A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice.
Clinical immunology (Orlando, Fla.) 2009;133(1):61-8.
2009: Uri Sela; Amir Sharabi; Molly Dayan; Rami Hershkoviz; Edna Mozes
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.
Immunology 2009;128(1 Suppl):e395-405.
2009: Zev M Sthoeger; Amir Sharabi; Yair Molad; Ilan Asher; Heidy Zinger; Molly Dayan; Edna Mozes
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.
Journal of autoimmunity 2009;33(1):77-82.
2009: Eirik Bratland; Geir Bredholt; Gunnar Mellgren; Per M Knappskog; Edna Mozes; Eystein S Husebye
The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.
Journal of autoimmunity 2009;33(1):58-67.
2009: Amir Sharabi; Edna Mozes
Harnessing regulatory T cells for the therapy of lupus and other autoimmune diseases.
Immunotherapy 2009;1(3):385-401.
2009: Reshmi Parameswaran; Hava Ben David; Amir Sharabi; Heidy Zinger; Edna Mozes
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
Clinical immunology (Orlando, Fla.) 2009;131(2):223-32.
2009: Zev M Sthoeger; Amir Sharabi; Molly Dayan; Heidy Zinger; Ilan Asher; Uri Sela; Edna Mozes
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.
Human immunology 2009;70(3):139-45.
2008: Amir Sharabi; Edna Mozes
The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(5):3243-51.
2008: Uri Sela; Molly Dayan; Rami Hershkoviz; Ofer Lider; Edna Mozes
A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(3):1584-91.
2008: Edna Mozes; Uri Sela; Amir Sharabi
A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action.
The Israel Medical Association journal : IMAJ 2008;10(1):40-2.
2007: Hava Ben David; Amir Sharabi; Molly Dayan; Michael Sela; Edna Mozes
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(44):17459-64.
2007: Amir Sharabi; Dror Luger; Hava Ben David; Molly Dayan; Heidy Zinger; Edna Mozes
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse model.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):4979-87.
2007: Anat Elmann; Amir Sharabi; Molly Dayan; Heidy Zinger; Ron Ophir; Edna Mozes
Altered gene expression in mice with lupus treated with edratide, a peptide that ameliorates the disease manifestations.
Arthritis and rheumatism 2007;56(7):2371-81.
2007: Hava Ben David; B Venkata Aruna; Michael Sela; Edna Mozes
A dual altered peptide ligand inhibits myasthenia gravis associated responses by inducing phosphorylated extracellular-regulated kinase 1,2 that upregulates CD4+CD25+Foxp3+ cells.
Scandinavian journal of immunology 2007;65(6):567-76.
2007: Amir Sharabi; Hava Azulai; Zev M Sthoeger; Edna Mozes
Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action.
Immunology 2007;121(2):248-57.
2006: Hava Ben David; Badiga Venkata Aruna; Rony Seger; Michael Sela; Edna Mozes
A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(48):18232-7.
2006: Uri Sela; Molly Dayan; Rami Hershkoviz; Liora Cahalon; Ofer Lider; Edna Mozes
The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses.
European journal of immunology 2006;36(11):2971-80.
2006: Badiga Venkata Aruna; Michael Sela; Edna Mozes
Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cells.
Journal of neuroimmunology 2006;177(1-2):63-75.
2006: Badiga Venkata Aruna; Hava Ben David; Michael Sela; Edna Mozes
A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis.
Immunology 2006;118(3):413-24.
2006: Amir Sharabi; Heidy Zinger; Maya Zborowsky; Zev M Sthoeger; Edna Mozes
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-beta.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(23):8810-5.
2006: Elena Voronov; Molly Dayan; Heidy Zinger; Lubov Gayvoronsky; Jian-Ping Lin; Yoichiro Iwakura; Ron N Apte; Edna Mozes
IL-1 beta-deficient mice are resistant to induction of experimental SLE.
European cytokine network 2006;17(2):109-16.
2006: Amir Sharabi; Asher Haviv; Heidy Zinger; Molly Dayan; Edna Mozes
Amelioration of murine lupus by a peptide, based on the complementarity determining region-1 of an autoantibody as compared to dexamethasone: different effects on cytokines and apoptosis.
Clinical immunology (Orlando, Fla.) 2006;119(2):146-55.
2006: Eystein S Husebye; Eirik Bratland; Geir Bredholt; Mati Fridkin; Molly Dayan; Edna Mozes
The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope.
Endocrinology 2006;147(5):2411-6.
2006: Zev M Sthoeger; Alexander Neiman; Daniel Elbirt; Heidy Zinger; Eli Magen; Rimona Burstein; Sara Eitan; Jakov Abarbanel; Edna Mozes
High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study.
The American journal of the medical sciences 2006;331(1):4-9.
2005: Uri Sela; Nora Mauermann; Rami Hershkoviz; Heidy Zinger; Molly Dayan; Liora Cahalon; Jian Ping Liu; Edna Mozes; Ofer Lider
The inhibition of autoreactive T cell functions by a peptide based on the CDR1 of an anti-DNA autoantibody is via TGF-beta-mediated suppression of LFA-1 and CD44 expression and function.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(11):7255-63.
2005: Micha J Rapoport; Amir Sharabi; Dorit Aharoni; Olga Bloch; Heidy Zinger; Molly Dayan; Edna Mozes
Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinase.
Clinical immunology (Orlando, Fla.) 2005;117(3):262-70.
2005: Eystein S Husebye; Zev M Sthoeger; Molly Dayan; Heidy Zinger; Daniel Elbirt; Mia Levite; Edna Mozes
Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 2005;64(8):1210-3.
2005: Badiga Venkata Aruna; Michael Sela; Edna Mozes
Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(29):10285-90.
2005: Hava Ben David; Michael Sela; Edna Mozes
Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(6):2028-33.
2005: Edna Mozes; J Lovchik; Heidy Zinger; dinah singer
MHC class I expression regulates susceptibility to spontaneous autoimmune disease in (NZBxNZW)F1 mice.
Lupus 2005;14(4):308-14.
2005: Uri Sela; Rami Hershkoviz; Liora Cahalon; Ofer Lider; Edna Mozes
Down-regulation of stromal cell-derived factor-1alpha-induced T cell chemotaxis by a peptide based on the complementarity-determining region 1 of an anti-DNA autoantibody via up-regulation of TGF-beta secretion.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(1):302-9.
2004: Dror Luger; Molly Dayan; Heidy Zinger; Jian-Ping Liu; Edna Mozes
A peptide based on the complementarity determining region 1 of a human monoclonal autoantibody ameliorates spontaneous and induced lupus manifestations in correlation with cytokine immunomodulation.
Journal of clinical immunology 2004;24(6):579-90.
2004: Michael Sela; Edna Mozes
Therapeutic vaccines in autoimmunity.
Proceedings of the National Academy of Sciences of the United States of America 2004;101 Suppl 2():14586-92.
2004: N Mauermann; Zev M Sthoeger; Heidy Zinger; Edna Mozes
Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.
Clinical and experimental immunology 2004;137(3):513-20.
2004: Molly Dayan; Zev M Sthoeger; Alex Neiman; Jacob Abarbanel; Michael Sela; Edna Mozes
Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Human immunology 2004;65(6):571-7.
2003: Rephael Segal; Molly Dayan; Heidy Zinger; Beno Habut; Gene M Shearer; Edna Mozes
The effect of IL-12 on clinical and laboratory aspects of experimental SLE in young and aging mice.
Experimental gerontology 2003;38(6):661-8.
2003: Miri Paas-Rozner; Michael Sela; Edna Mozes
A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(11):6676-81.
2003: Zev M Sthoeger; Heidy Zinger; Edna Mozes
Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies.
Annals of the rheumatic diseases 2003;62(4):341-6.
2003: Zev M Sthoeger; Heidy Zinger; Benjamin Dekel; Fabian Arditi; Yair Reisner; Edna Mozes
Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras.
Journal of clinical immunology 2003;23(2):91-9.
2003: Heidy Zinger; Eran Eilat; Asher Meshorer; Edna Mozes
Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression.
International immunology 2003;15(2):205-14.
2003: Zev M Sthoeger; Molly Dayan; A Tcherniack; L Green; S Toledo; R Segal; O Elkayam; Edna Mozes
Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies.
Clinical and experimental immunology 2003;131(2):385-92.
2002: Anat Faber-Elmann; Eran Eilat; Heidy Zinger; Edna Mozes
A peptide based on an anti-DNA autoantibody downregulates matrix metalloproteinases in murine models of lupus.
Clinical immunology (Orlando, Fla.) 2002;105(2):223-32.
2002: Naama Brosh; Heidy Zinger; Edna Mozes
Treatment of induced murine SLE with a peptide based on the CDR3 of an anti-DNA antibody reverses the pattern of pathogenic cytokines.
Autoimmunity 2002;35(3):211-9.
2002: Anat Faber-Elmann; Zev M Sthoeger; A Tcherniack; Molly Dayan; Edna Mozes
Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.
Clinical and experimental immunology 2002;127(2):393-8.
2001: Miri Paas-Rozner; Michael Sela; Edna Mozes
The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(22):12642-7.
2001: Eran Eilat; Molly Dayan; Heidy Zinger; Edna Mozes
The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(3):1148-53.
2001: R Segal; Molly Dayan; Heidy Zinger; Edna Mozes
Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphylline.
Lupus 2001;10(1):23-31.
2001: Anat Faber-Elmann; Valentin Grabovsky; Molly Dayan; Michael Sela; Ronen Alon; Edna Mozes
An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(1):187-194.
2000: Anat Faber-Elmann; Valentin Grabovsky; Molly Dayan; Michael Sela; Ronen Alon; Edna Mozes
Cytokine profile and T cell adhesiveness to endothelial selectins: in vivo induction by a myasthenogenic T cell epitope and immunomodulation by a dual altered peptide ligand.
International immunology 2000;12(12):1651-8.
2000: Jolynne R Tschetter; Edna Mozes; Gene M Shearer
Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(10):5987-94.
2000: Eran Eilat; Mati Fridkin; Edna Mozes
A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells.
Immunobiology 2000;202(4):383-93.
2000: Naama Brosh; Heidy Zinger; Mati Fridkin; Edna Mozes
A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs.
Cellular immunology 2000;205(1):52-61.
2000: Eran Eilat; Heidy Zinger; A Nyska; Edna Mozes
Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody.
Journal of clinical immunology 2000;20(4):268-78.
2000: Molly Dayan; R Segal; Zev M Sthoeger; Ari Waisman; Naama Brosh; O Elkayam; Eran Eilat; Mati Fridkin; Edna Mozes
Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.
Journal of clinical immunology 2000;20(3):187-94.
2000: Naama Brosh; Molly Dayan; Mati Fridkin; Edna Mozes
A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice.
Immunology letters 2000;72(1):61-8.
2000: Molly Dayan; Rephael Segal; Amiela Globerson; Beno Habut; Gene M Shearer; Edna Mozes
Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus-afflicted mice.
Experimental gerontology 2000;35(2):225-36.
2000: Miri Paas-Rozner; Molly Dayan; Y Paas; Jean-Pierre Changeux; I Wirguin; Michael Sela; Edna Mozes
Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(5):2168-73.
2000: Naama Brosh; Eran Eilat; Heidy Zinger; Edna Mozes
Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibody.
Immunology 2000;99(2):257-65.
2000: Leonard D Kohn; Giorgio Napolitano; dinah singer; M Molteni; R Scorza; N Shimojo; Y Kohno; Edna Mozes; Minoru Nakazato; Luca Ulianich; Hyun-Kyung Chung; H Matoba; Bertrand Saunier; Koichi Suzuki; Frank Schuppert; Motoyasu Saji
Graves' disease: a host defense mechanism gone awry.
International reviews of immunology 2000;19(6):633-64.
1999: Miri Blank; Ari Waisman; Edna Mozes; Takao Koike; Yehuda Shoenfeld
Characteristics and pathogenic role of anti-beta2-glycoprotein I single-chain Fv domains: induction of experimental antiphospholipid syndrome.
International immunology 1999;11(12):1917-26.
1999: Amnon Zisman; Arie Lindner; Einat Zisman; U Lindner; Edna Mozes
Prostate-specific antigen induces proliferation of peripheral blood lymphocytes and cytokine secretion in benign prostate hypertrophy patients.
European urology 1999;36(3):258-65.
1999: dinah singer; Heidy Zinger; Leonard D Kohn; Edna Mozes
Differing MHC class I requirements for induction and propagation of experimental systemic lupus erythematosus.
European journal of immunology 1999;29(7):2259-68.
1999: Shlomo Mendlovic; Edna Mozes; Eran Eilat; Adiel Doron; J Lereya; V Zakuth; Zvi Spirer
Immune activation in non-treated suicidal major depression.
Immunology letters 1999;67(2):105-8.
1999: Roald Nezlin; Molly Dayan; Heidy Zinger; Edna Mozes
DNA levels in immune complexes circulating in mice with induced systemic lupus erythematosus.
Immunology letters 1999;67(2):85-90.
1998: Anat Faber-Elmann; Miri Paas-Rozner; Michael Sela; Edna Mozes
Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14320-5.
1998: PJ Ruiz; Ari Waisman; Edna Mozes
Anti-T-cell receptor therapy in murine experimental systemic lupus erythematosus.
Immunology letters 1998;62(1):1-8.
1998: Y Katz-Levy; Molly Dayan; I Wirguin; Mati Fridkin; Michael Sela; Edna Mozes
Single amino acid analogs of a myasthenogenic peptide modulate specific T cell responses and prevent the induction of experimental autoimmune myasthenia gravis.
Journal of neuroimmunology 1998;85(1):78-86.
1998: Edna Mozes; Heidy Zinger; Leonard D Kohn; dinah singer
Spontaneous autoimmune disease in (NZB x NZW)F1 mice is ameliorated by treatment with methimazole.
Journal of clinical immunology 1998;18(2):106-13.
1997: Edna Mozes; D Alling; M W Miller; S M Payne; Heidy Zinger; Charles S Via; Gene M Shearer
Genetic analysis of experimentally induced lupus in mice.
Clinical immunology and immunopathology 1997;85(1):28-34.
1997: SL Kirshner; Ari Waisman; Einat Zisman; Avraham Ben-Nun; Edna Mozes
T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide.
Cellular immunology 1997;180(1):20-8.
1997: Rephael Segal; Molly Dayan; Amiela Globerson; Beno Habut; Gene M Shearer; Edna Mozes
Effect of aging on cytokine production in normal and experimental systemic lupus erythematosus afflicted mice.
Mechanisms of ageing and development 1997;96(1-3):47-58.
1997: M Dayan; R Segal; Edna Mozes
Cytokine manipulation by methotrexate treatment in murine experimental systemic lupus erythematosus.
The Journal of rheumatology 1997;24(6):1075-82.
1997: Avi Karni; Einat Zisman; Y Katz-Levy; Miri Paas-Rozner; Molly Dayan; Chaim Brautbar; Oded Abramsky; Michael Sela; Edna Mozes
Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor.
Neurology 1997;48(6):1638-42.
1997: Ari Waisman; PJ Ruiz; E Israeli; Eran Eilat; S Könen-Waisman; Heidy Zinger; Molly Dayan; Edna Mozes
Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(9):4620-5.
1997: Zev M Sthoeger; Molly Dayan; Heidy Zinger; Francis Kalush; G Mor; Y A Zaltman; F Kohen; Edna Mozes
Treatments with tamoxifen and an antiestradiol antibody have beneficial effects on experimental SLE via cytokine modulation.
Annals of the New York Academy of Sciences 1997;815():367-8.
1997: Y Katz-Levy; Miri Paas-Rozner; SL Kirshner; Molly Dayan; Einat Zisman; Mati Fridkin; I Wirguin; Michael Sela; Edna Mozes
A peptide composed of tandem analogs of two myasthenogenic T cell epitopes interferes with specific autoimmune responses.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(7):3200-5.
1997: R Segal; B L Bermas; Molly Dayan; Francis Kalush; G M Shearer; Edna Mozes
Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(6):3009-16.
1997: dinah singer; Edna Mozes; SL Kirshner; Leonard D Kohn
Role of MHC class I molecules in autoimmune disease.
Critical reviews in immunology 1997;17(5-6):463-8.
1997: Molly Dayan; Heidy Zinger; Francis Kalush; G Mor; Y Amir-Zaltzman; F Kohen; Zev M Sthoeger; Edna Mozes
The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations.
Immunology 1997;90(1):101-8.
1996: B Tartakovsky; B L Bermas; Zev M Sthoeger; G M Shearer; Edna Mozes
Defective maternal-fetal interaction in a murine autoimmune model.
Human reproduction (Oxford, England) 1996;11(11):2408-11.
1996: S L Kirshner; Einat Zisman; Mati Fridkin; Michael Sela; Edna Mozes
Altered peptide ligands of a myasthenogenic epitope as modulators of specific T-cell responses.
Scandinavian journal of immunology 1996;44(5):512-21.
1996: Ari Waisman; Einat Zisman; Edna Mozes
MHC class II-mediated T cell response to DNA.
Cellular immunology 1996;173(1):7-14.
1996: Ari Waisman; Pedro J Ruiz; Edna Mozes
Variable regions of two murine antibodies that bind the SLE associated 16/6 idiotype.
Lupus 1996;5(4):279-87.
1996: BB Mittleman; Herbert C Morse; S M Payne; Gene M Shearer; Edna Mozes
Amelioration of experimental systemic lupus erythematosus (SLE) by retrovirus infection.
Journal of clinical immunology 1996;16(4):230-6.
1996: Einat Zisman; Y Katz-Levy; Molly Dayan; S L Kirshner; Miri Paas-Rozner; Avi Karni; Oded Abramsky; Chaim Brautbar; Mati Fridkin; Michael Sela; Edna Mozes
Peptide analogs to pathogenic epitopes of the human acetylcholine receptor alpha subunit as potential modulators of myasthenia gravis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(9):4492-7.
1996: P J Ruiz; Heidy Zinger; Edna Mozes
Effect of injection of anti-CD4 and anti-CD8 monoclonal antibodies on the development of experimental systemic lupus erythematosus in mice.
Cellular immunology 1996;167(1):30-7.
1996: Zev M Sthoeger; B Tartakovsky; Mina Fogel; Y Lasri; Edna Mozes
Anticardiolipin, but not the 16/6 Id anti-DNA antibody induces pregnancy failure.
Immunology letters 1996;49(1-2):117-22.
1996: Edna Mozes; R Segal; Zev M Sthoeger; Molly Dayan; Heidy Zinger; L D Kohn; dinah singer
Modulation of experimental systemic lupus erythematosus.
Israel journal of medical sciences 1996;32(1):19-21.
1995: Einat Zisman; Chaim Brautbar; Michael Sela; Oded Abramsky; S Battat; S L Kirshner; Y Katz-Levy; Molly Dayan; Edna Mozes
Binding of peptides of the human acetylcholine receptor alpha-subunit to HLA class II of patients with myasthenia gravis.
Human immunology 1995;44(3):121-30.
1995: Roald Nezlin; Edna Mozes
Detection of antigens in immune complexes by a dot blot assay.
Journal of immunological methods 1995;184(2):273-6.
1995: R Segal; Molly Dayan; Heidy Zinger; Edna Mozes
Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation.
Clinical and experimental immunology 1995;101(1):66-72.
1995: Mia Levite; Heidy Zinger; Einat Zisman; Yair Reisner; Edna Mozes
Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
Cellular immunology 1995;162(1):138-45.
1995: Ari Waisman; Yehuda Shoenfeld; Miri Blank; Pedro J Ruiz; Edna Mozes
The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment.
International immunology 1995;7(4):689-96.
1995: Michael Sela; S L Kirshner; Y Katz-Levy; Einat Zisman; Edna Mozes
Dominant epitopes and synthetic peptides in myasthenia gravis.
Israel journal of medical sciences 1995;31(1):10-2.
1994: Einat Zisman; Michael Sela; Avraham Ben-Nun; Edna Mozes
Dichotomy between the T and the B cell epitopes of the synthetic polypeptide (T,G)-A--L.
European journal of immunology 1994;24(10):2497-505.
1994: B L Bermas; Michelle Petri; Jay A Berzofsky; Ari Waisman; Gene M Shearer; Edna Mozes
Binding of glycoprotein 120 and peptides from the HIV-1 envelope by autoantibodies in mice with experimentally induced systemic lupus erythematosus and in patients with the disease.
AIDS research and human retroviruses 1994;10(9):1071-7.
1994: Francis Kalush; E Rimon; A Keller; Edna Mozes
Neonatal lupus erythematosus with cardiac involvement in offspring of mothers with experimental systemic lupus erythematosus.
Journal of clinical immunology 1994;14(5):314-22.
1994: G Ast; D Goldblatt; Ari Waisman; Ruth Sperling; Edna Mozes; Joseph Sperling
An autoantibody derived from mice with experimental systemic lupus erythematosus is directed against the essential splicing factor SF53/4--a possible role for large nuclear ribonucleoprotein particles in autoimmune disorders.
International immunology 1994;6(8):1097-105.
1994: S L Kirshner; Y Katz-Levy; I Wirguin; Zohar Argov; Edna Mozes
Fine specificity of T cell lines and clones that are capable of inducing autoimmune manifestations in mice.
Cellular immunology 1994;157(1):11-28.
1994: dinah singer; Leonard D Kohn; Heidy Zinger; Edna Mozes
Methimazole prevents induction of experimental systemic lupus erythematosus in mice.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(2):873-80.
1994: Pedro J Ruiz; Heidy Zinger; Edna Mozes
Induction of experimental systemic lupus erythematosus in mice by immunization with the F(ab')2 fragment of the human anti-DNA monoclonal antibody carrying the 16/6 idiotype.
Immunology letters 1994;41(1):79-84.
1994: Einat Zisman; Edna Mozes
Processing requirements of two acetylcholine receptor derived peptides for binding to antigen presenting cells and stimulation of murine T cell lines.
International immunology 1994;6(5):683-91.
1994: Edna Mozes
The role of genetic factors in autoimmunity.
Israel journal of medical sciences 1994;30(3):34-6.
1994: R Segal; Amiela Globerson; Heidy Zinger; Edna Mozes
Inhibition of autoantibody production in experimental SLE by pre-immunization with DNA.
Autoimmunity 1994;17(2):149-56.
1993: Ari Waisman; S Mendlovic; Pedro J Ruiz; Heidy Zinger; A Meshorer; Edna Mozes
The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus.
International immunology 1993;5(10):1293-300.
1993: Mia Levite; Heidy Zinger; Edna Mozes; Yair Reisner
Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Bone marrow transplantation 1993;12(3):179-83.
1993: Y Katz-Levy; S L Kirshner; Michael Sela; Edna Mozes
Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(15):7000-4.
1993: Zev M Sthoeger; Edna Mozes; B Tartakovsky
Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(14):6464-7.
1993: Edna Mozes; Leonard D Kohn; Frances T Hakim; dinah singer
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus.
Science (New York, N.Y.) 1993;261(5117):91-3.
1993: Ari Waisman; Edna Mozes
Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus.
European journal of immunology 1993;23(7):1566-73.
1993: Zev M Sthoeger; B Tartakovsky; Z Bentwich; Edna Mozes
Monoclonal anticardiolipin antibodies derived from mice with experimental lupus erythematosus: characterization and the induction of a secondary antiphospholipid syndrome.
Journal of clinical immunology 1993;13(2):127-38.
1993: Einat Zisman; Molly Dayan; Michael Sela; Edna Mozes
Ia-antigen-T-cell interactions for a thymus-independent antigen composed of D amino acids.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(3):994-8.
1992: Francis Kalush; E Rimon; Edna Mozes
Neonatal lupus erythematosus in offspring of mothers with experimental systemic lupus erythematosus.
American journal of reproductive immunology (New York, N.Y. : 1989) 1992;28(3-4):264-8.
1992: R Segal; Amiela Globerson; Heidy Zinger; Edna Mozes
The influence of aging on the induction and manifestations of experimental systemic lupus erythematosus.
Journal of clinical immunology 1992;12(5):341-6.
1992: R Segal; Amiela Globerson; Heidy Zinger; Edna Mozes
Induction of experimental systemic lupus erythematosus (SLE) in mice with severe combined immunodeficiency (SCID).
Clinical and experimental immunology 1992;89(2):239-43.
1992: Michael Sela; Edna Mozes; Einat Zisman; K A Muszkat; Bilha Schechter
A tale of two peptides, TyrTyrGluGlu and TyrGluTyrGlu, and their diverse immune behaviour.
Behring Institute Mitteilungen 1992;(91):54-66.
1992: Edna Mozes; Ari Waisman; Mia Levite; Heidy Zinger; Yair Reisner; Zev M Sthoeger
Update on experimental systemic lupus erythematosus.
Israel journal of medical sciences 1992;28(2):136-8.
1991: Einat Zisman; Michael Sela; Edna Mozes
Direct binding of a synthetic multichain polypeptide to class II major histocompatibility complex molecules on antigen-presenting cells and stimulation of a specific T-cell line require processing of the polypeptide.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(21):9738-42.
1991: Miri Blank; S Mendlovic; Edna Mozes; A R Coates; Yehuda Shoenfeld
Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+).
Clinical immunology and immunopathology 1991;60(3):471-83.
1991: H Fricke; S Mendlovic; Miri Blank; Yehuda Shoenfeld; M Ben-Bassat; Edna Mozes
Idiotype specific T-cell lines inducing experimental systemic lupus erythematosus in mice.
Immunology 1991;73(4):421-7.
1991: Y Tomer; S Mendlovic; T Kukulansky; Edna Mozes; Yehuda Shoenfeld; Amiela Globerson
Effects of aging on the induction of experimental systemic lupus erythematosus (SLE) in mice.
Mechanisms of ageing and development 1991;58(2-3):233-44.
1991: O Elkayam; Heidy Zinger; Einat Zisman; R Segal; M Yaron; Chaim Brautbar; Edna Mozes
Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis.
The Journal of rheumatology 1991;18(4):516-21.
1991: S Mendlovic; Y Levy; Edna Mozes
Specific proliferative responses following the induction of experimental SLE in mice.
Immunology letters 1991;27(1):69-73.
1991: Yehuda Shoenfeld; Edna Mozes
Pathogenic anti-DNA idiotype (16/6 Id) in systemic lupus erythematosus.
Rheumatology international 1991;11(3):91-3.
1990: Edna Mozes; S Mendlovic; Francis Kalush; Ari Waisman; Yehuda Shoenfeld; H Fricke
Immunoregulation of autoimmune diseases.
Israel journal of medical sciences 1990;26(12):688-90.
1990: S Mendlovic; R Segal; Yehuda Shoenfeld; Edna Mozes
Anti-DNA idiotype- and anti-idiotype-specific T cell responses in patients with systemic lupus erythematosus and their first-degree relatives.
Clinical and experimental immunology 1990;82(3):504-8.
1990: Daniel Offen; S Mendlovic; H Fricke; Ruth Sperling; Joseph Sperling; Edna Mozes
Monoclonal anti-La antibody derived from a mouse with experimental SLE is similar to human anti-La antibodies.
Journal of autoimmunity 1990;3(6):701-13.
1990: Yehuda Shoenfeld; Edna Mozes
Pathogenic idiotypes of autoantibodies in autoimmunity: lessons from new experimental models of SLE.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1990;4(9):2646-51.
1990: S Brocke; Molly Dayan; J Rothbard; Sara Fuchs; Edna Mozes
The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
Immunology 1990;69(4):495-500.
1990: Miri Blank; S Mendlovic; H Fricke; Edna Mozes; N Talal; Yehuda Shoenfeld
Sex hormone involvement in the induction of experimental systemic lupus erythematosus by a pathogenic anti-DNA idiotype in naive mice.
The Journal of rheumatology 1990;17(3):311-7.
1990: S Mendlovic; S Brocke; H Fricke; Yehuda Shoenfeld; R Bakimer; Edna Mozes
The genetic regulation of the induction of experimental SLE.
Immunology 1990;69(2):228-36.
1990: Miri Blank; M Krup; S Mendlovic; H Fricke; Edna Mozes; N Talal; A R Coates; Yehuda Shoenfeld
The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice.
Scandinavian journal of immunology 1990;31(1):45-52.
1990: Edna Mozes; S Mendlovic
The role of anti-DNA idiotype antibodies in systemic lupus erythematosus.
Critical reviews in immunology 1990;10(4):329-45.
1990: H Fricke; Daniel Offen; S Mendlovic; Yehuda Shoenfeld; R Bakimer; Joseph Sperling; Edna Mozes
Induction of experimental systemic lupus erythematosus in mice by immunization with a monoclonal anti-La autoantibody.
International immunology 1990;2(3):225-30.
1990: S Brocke; Molly Dayan; Lawrence Steinman; J Rothbard; Edna Mozes
Inhibition of T cell proliferation specific for acetylcholine receptor epitopes related to myasthenia gravis with antibody to T cell receptor or with competitive synthetic polymers.
International immunology 1990;2(8):735-42.
1989: Edna Mozes; Molly Dayan; Einat Zisman; S Brocke; A Licht; Israel Pecht
Direct binding of a myasthenia gravis related epitope to MHC class II molecules on living murine antigen-presenting cells.
The EMBO journal 1989;8(13):4049-52.
1989: Edna Mozes; S Brocke; H Fricke; Molly Dayan; Yehuda Shoenfeld; S Mendlovic
New experimental autoimmune models.
Israel journal of medical sciences 1989;25(12):692-5.
1989: Edna Mozes; S Brocke; Yehuda Shoenfeld; S Mendlovic
The role of the idiotypic network in the induction of experimental systemic lupus erythematosus.
Journal of cellular biochemistry 1989;40(2):173-81.
1989: B Tartakovsky; O Axelrod; T Blankenstein; Edna Mozes
Correlation between the biologic functions and the generation of lymphokines in T cell clones.
Journal of immunology (Baltimore, Md. : 1950) 1989;142(8):2695-701.
1989: S Mendlovic; H Fricke; Yehuda Shoenfeld; Edna Mozes
The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice.
European journal of immunology 1989;19(4):729-34.
1988: Edna Mozes; Yehuda Shoenfeld; S Brocke; S Mendlovic
Induction of experimental systemic lupus erythematosus in mice.
Israel journal of medical sciences 1988;24(12):741-4.
1988: S Brocke; Chaim Brautbar; Lawrence Steinman; Oded Abramsky; J Rothbard; D Neumann; Sara Fuchs; Edna Mozes
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
The Journal of clinical investigation 1988;82(6):1894-900.
1988: Edna Mozes; S Mendlovic; Z Bentwich; Chaim Brautbar; Yehuda Shoenfeld
T-cell-helper factors in autoimmunity.
Israel journal of medical sciences 1988;24(7):355-8.
1988: S Mendlovic; Yehuda Shoenfeld; R Bakimer; R Segal; Molly Dayan; Edna Mozes
In vitro T-cell functions specific to an anti-DNA idiotype and serological markers in patients with systemic lupus erythematosus (SLE).
Journal of clinical immunology 1988;8(3):178-87.
1988: S Mendlovic; S Brocke; Yehuda Shoenfeld; M Ben-Bassat; A Meshorer; R Bakimer; Edna Mozes
Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2260-4.
1987: Edna Mozes; Heidy Zinger
Characterization and biologic activities of an anti-idiotype-specific T cell line and its derived clones.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(11):3564-9.
1987: M Tishler; Chaim Brautbar; S Battat; Molly Dayan; Edna Mozes
Analysis of the antigen specific helper T cell function and HLA-DR of Israeli patients with rheumatoid arthritis (RA).
Tissue antigens 1987;30(5):229-34.
1987: O Axelrod; Edna Mozes
Mode of action of antigen-specific T-cell helper factors secreted by a T-cell line and clones.
Journal of immunogenetics 1987;14(2-3):109-15.
1987: Edna Mozes; Heidy Zinger; O Axelrod
T-cell clones specific for synthetic polypeptides in cellular collaborations.
Advances in experimental medicine and biology 1987;225():165-81.
1986: M Tishler; Chaim Brautbar; M Yaron; Molly Dayan; Edna Mozes
Association between HLA-DR4 and production of collagen-specific antibodies in Israeli patients with rheumatoid arthritis.
Israel journal of medical sciences 1986;22(11):771-3.